Diagnosis of CNS Toxoplasmosis
A presumptive diagnosis of CNS toxoplasmosis in immunocompromised patients is based on the triad of clinical symptoms, serologic evidence of infection (though negative serology does not exclude the diagnosis), and the presence of space-occupying lesions on brain imaging, with MRI being more sensitive than CT. 1
Diagnostic Approach
Initial Clinical Assessment
Look for these specific neurologic findings in immunocompromised patients:
- Focal neurologic deficits (most typical presentation, especially hemiparesis)
- Fever with reduced alertness
- Seizures
- Mental status changes
- Adynamia (profound weakness)
Note that the presentation can be variable—some patients present with diffuse rather than focal CNS disease 1, 2.
Serologic Testing
- Check Toxoplasma IgG antibodies as part of the initial workup 1
- Critical caveat: Cases of Toxoplasma encephalitis have been documented in persons without Toxoplasma-specific IgG antibodies; therefore, negative serology does not exclude the diagnosis 1
- Detection of specific IgG in CSF can confirm diagnosis but has low sensitivity 2
Neuroimaging (Essential)
MRI is the preferred imaging modality as it is more sensitive than CT and will confirm lesions in the majority of patients 1:
- Typical findings: Multiple, bilateral, ring-enhancing lesions
- Characteristic locations: Basal ganglia and cerebral corticomedullary junction
- CT may show these lesions but is less sensitive
FDG-PET can help distinguish Toxoplasma abscesses from primary CNS lymphoma, but accuracy is not high and availability is limited 1.
Molecular Diagnosis
PCR for Toxoplasma gondii DNA should be performed on:
- Cerebrospinal fluid (preferred for CNS disease) 1, 3, 4, 5
- Blood (particularly useful in transplant patients) 3
PCR performance characteristics from research evidence:
- CSF PCR shows 68.8% sensitivity, 100% specificity, 100% positive predictive value, and 87.8% negative predictive value 4
- PCR is fast (results within 4 hours) and highly specific 4, 5
- Important limitation: PCR in blood can be negative even in active toxoplasma disease 6
Definitive Diagnosis
Brain biopsy provides definitive diagnosis through histologic or cytologic confirmation, demonstrating:
- Leptomeningeal inflammation
- Microglial nodules
- Gliosis
- Toxoplasma cysts
Biopsy should be considered when 1:
- Early neurologic deterioration occurs despite empiric treatment
- Patients fail to respond to anti-Toxoplasma therapy after 10-14 days
Diagnostic Algorithm Summary
- Suspect CNS toxoplasmosis in any immunocompromised patient with new neurologic findings
- Obtain MRI brain (preferred over CT) looking for multiple ring-enhancing lesions in basal ganglia
- Check Toxoplasma IgG serology (but proceed with workup even if negative)
- Perform lumbar puncture for CSF PCR (if safe to do so)
- Consider blood PCR especially in transplant recipients
- Initiate empiric therapy if clinical and radiologic findings are consistent
- Reserve brain biopsy for cases with early deterioration or failure to respond after 10-14 days of treatment
Common Pitfalls
- Do not rule out toxoplasmosis based on negative serology alone—documented cases exist in seronegative patients 1
- Do not rely solely on CT imaging—MRI is significantly more sensitive 1
- Do not delay empiric treatment while awaiting PCR results in clinically compatible cases
- Remember that PCR can be falsely negative, particularly blood PCR in established disease 6
The guidelines emphasize that in the appropriate clinical context (immunocompromised patient with compatible symptoms and imaging), presumptive diagnosis is sufficient to initiate treatment, with definitive confirmation reserved for atypical or treatment-refractory cases 1.